Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era-Reference-Cited by-同舟云学术

Causes of death of patients with follicular lymphoma in the Netherlands by stage and age groups: a population-based study in the pre- and post-rituximab era

Published:2022-03-04 Issue:5 Volume:36 Page:1416-1420
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Dinnessen Manette A. W.^ORCID,Maas Carolien C. H. M.,Tonino Sanne H.,Visser Otto,Posthuma Eduardus F. M.,Blijlevens Nicole M. A.,Kersten Marie José,Lugtenburg Pieternella J.,Dinmohamed Avinash G.^ORCID

Funder

Honoraria from Incyte, Takeda, Celgene and travel support form Roche/ Gilead.

Research support from Kite/Gilead and honoraria and/or travel support from Kite/Gilead, Novartis, Miltenyi Biotech, Roche, BMS/Celgene

Research funding from Takeda, Servier, Roche and honoraria for advisory boards from Takeda, Servier, Roche, Genmab, Incyte, Regeneron, Celgene

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-022-01535-y.pdf

Reference14 articles.

1. Dinnessen MAW, van der Poel MWM, Tonino SH, Visser O, Blijlevens NMA, de Jong D, et al. Stage-specific trends in primary therapy and survival in follicular lymphoma: a nationwide population-based analysis in the Netherlands, 1989-2016. Leukemia. 2021;35:1683–95.